Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Fentanyl Human Trafficking topic
No spam. Unsubscribe anytime.
Oversight committee recaps fentanyl and human‑trafficking testimony, forwards recommendation letter
Summary
The committee recapped multiple presentations on fentanyl, law enforcement responses and human‑trafficking interventions and circulated a letter of recommendations to House leadership addressing pill presses, penalties and Xylazine.
Get email alerts on the Fentanyl Human Trafficking topic
No spam. Unsubscribe anytime.
The House Oversight Committee on Homeland Security and Foreign Influence reviewed past testimony on fentanyl and human trafficking and discussed a letter of recommendations the committee prepared for House leadership.
Chair Brook summarized a series of presenters the committee hosted on fentanyl and related enforcement and treatment issues, saying the committee had “very quickly went into fentanyl” after its kickoff presentation and had remained on the topic for multiple meetings. He identified presenters including Michael Bouchard, Berrien County Sheriff Chuck Hite, Monroe County law‑enforcement representatives describing the VIPER program, and a medical presenter identified in the transcript as Dr. Bagdair Syrian who spoke about treatment and recovery.
Committee members described the testimony as “eye opening.” Representative Meerman said the fentanyl presentations showed the wider context for homeland security issues. Several members referenced a letter included in the committee packet that the chair said had been submitted to House leadership; Chair Brook described it as a set of recommendations to address pill presses, support stiffer penalties for fentanyl dealers and to address issues related to Xylazine.
Representative Shriver reiterated the link she sees between human trafficking and the pornography industry and said she is working on legislation she described as holding producers and disseminators accountable; that measure was discussed as concept and no formal bill was introduced at this meeting. Chair Brook said the committee’s packet included the letter of recommendation and that staff had worked with drafters and stakeholders on possible legislative language.
Committee members also described other programs mentioned in prior testimony, including VIPER and local task forces, and asked staff to bring additional data and presenters. Chair Brook said the next meeting was to include a presentation on human‑trafficker data from the Michigan State Police and that the committee will continue with further testimony and drafting work.
Ending: The committee did not vote on fentanyl‑related legislation at this meeting; members directed staff to continue coordinating with House leadership and to schedule additional testimony from law enforcement and treatment providers.

